CELLECTIS S.A.
Last · Paris€1.074-0.054 (-4.79%)stale · yahoo · 44h ago
Market cap€108.2M72.7M sh
P/E · TTM-2.0fwd -0.7 · eps -0.55 · loss
Beta2.91vs S&P 500
Div yield0.00%annual · TTM
52w range
€1.04€4.84
Volume366.4Ksession
| Revenue | €283 |
|---|---|
| Period | 2024 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2025-03-13
- Net Margin Sharply Negative
Red flags
- Net Margin Sharply Negative — Net margin -14768.6%
Upcoming earnings
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
13.5M
Earnings transcripts
Press & signals
- GlobeNewswire
Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company
- GlobeNewswire
Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update
- GlobeNewswire
Monthly information on share capital and company voting rights
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags